Hydroxyethyl Starch in Sodium Chloride (B. Braun Medical Inc.)
Welcome to the PulseAid listing for the Hydroxyethyl Starch in Sodium Chloride drug offered from B. Braun Medical Inc.. This Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA],Starch [Chemical/Ingredient],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | B. Braun Medical Inc. |
NON-PROPRIETARY NAME: | Hydroxyethyl Starch in Sodium Chloride |
SUBSTANCE NAME: | HYDROXYETHYL STARCH 130/0.4; SODIUM CHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA],Starch [Chemical/Ingredient],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-01-09 |
END MARKETING DATE: | 0000-00-00 |
Hydroxyethyl Starch in Sodium Chloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Hydroxyethyl Starch in Sodium Chloride from B. Braun Medical Inc. |
LABELER NAME: | B. Braun Medical Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 6; 900(g/100mL; mg/100mL) |
START MARKETING DATE: | 2015-01-09 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0264-1968_79f3c629-3cc6-4ee7-82e8-6ca0d5ba1f4c |
PRODUCT NDC: | 0264-1968 |
APPLICATION NUMBER: | ANDA110013 |
Other HYDROXYETHYL STARCH 130/0.4; SODIUM CHLORIDE Pharmaceutical Manufacturers / Labelers: